Skip to main content
SpringerLink
Log in

Refining clinical decision strategies and prostate cancer detection through fine adjustments in the combination of PSA-derived parameters and MRI

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 28 March 2024

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Padhani AR, Godtman RA, Schoots IG (2024) Key learning on the promise and limitations of MRI in prostate cancer screening. Eur Radiol. https://doi.org/10.1007/s00330-024-10626-6

  2. Stolk TT, de Jong IJ, Kwee TC et al (2019) False positives in PIRADS (V2) 3, 4, and 5 lesions: relationship with reader experience and zonal location. Abdom Radiol (NY) 44:1044–1051

    Article  PubMed  Google Scholar 

  3. Walker SM, Mehralivand S, Harmon SA et al (2020) Prospective evaluation of PI-RADS version 2.1 for prostate cancer detection. AJR Am J Roentgenol 215(5):1098–1103. https://doi.org/10.2214/AJR.19.22679

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hamm C, Baumgärtner GL, Padhani A et al (2024) Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies. Eur Radiol. https://doi.org/10.1007/s00330-024-10700-z

  5. Washino S, Okochi T, Saito K et al (2017) Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients BJU Int 119(2):225–233. https://doi.org/10.1111/bju.13465

    Article  CAS  PubMed  Google Scholar 

  6. Falagario UG, Jambor I, Lantz A et al (2021) Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the prostate magnetic resonance imaging outcome database (PROMOD). Eur Urol Oncol 4(6):971–979. https://doi.org/10.1016/j.euo.2020.08.014

    Article  PubMed  Google Scholar 

  7. Mottet N, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 79(2):243–262. https://doi.org/10.1016/j.eururo.2020.09.042

    Article  CAS  PubMed  Google Scholar 

  8. Schoots IG, Padhani AR (2021) Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int 127(2):175–178. https://doi.org/10.1111/bju.15277

    Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Department of Medical Images, Oncology and Hematology, Ribeirao Preto School of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil

    Valdair Francisco Muglia

Authors
  1. Valdair Francisco Muglia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valdair Francisco Muglia.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Valdair F Muglia.

Conflict of interest

The author of this manuscript declares no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was not required.

Ethical approval

Institutional Review Board approval was not required.

Study subjects or cohorts overlap

Not applicable.

Methodology

  • Commentary

Additional information

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-024-10700-z.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muglia, V.F. Refining clinical decision strategies and prostate cancer detection through fine adjustments in the combination of PSA-derived parameters and MRI. Eur Radiol (2024). https://doi.org/10.1007/s00330-024-10734-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00330-024-10734-3

Search

Navigation